Get the Stockscreener App
21.76
1.94%
-0.43
Beta Bionics Inc stock is traded at $21.76, with a volume of 906.85K.
It is down -1.94% in the last 24 hours and up +10.29% over the past month.
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.
See More
Previous Close:
$22.19
Open:
$22.31
24h Volume:
906.85K
Relative Volume:
0.71
Market Cap:
$1.17B
Revenue:
$110.24M
Net Income/Loss:
$-66.44M
P/E Ratio:
-14.40
EPS:
-1.5111
Net Cash Flow:
$-61.12M
1W Performance:
+1.54%
1M Performance:
+10.29%
6M Performance:
+93.59%
1Y Performance:
-4.27%
1-Day Range:
$21.44
$22.62
1-Week Range:
$21.10
$23.56
52-Week Range:
$8.80
$32.71
Beta Bionics Inc Stock (BBNX) Company Profile
Name
Beta Bionics Inc
Sector
Industry
Phone
949-427-7785
Address
11 HUGHES, IRVINE
Compare BBNX vs ABT, MDT, SYK, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BBNX
Beta Bionics Inc
|
21.76 | 1.17B | 110.24M | -66.44M | -61.12M | -1.5111 |
ABT
Abbott Laboratories
|
101.07 | 174.89B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
88.51 | 113.22B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
269.75 | 103.47B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
44.68 | 64.75B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
85.73 | 49.41B | 6.30B | 1.07B | 1.09B | 1.8406 |
Beta Bionics Inc Stock (BBNX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-09-26 | Initiated | UBS | Buy |
| Jan-27-26 | Initiated | TD Cowen | Hold |
| Jan-09-26 | Downgrade | BofA Securities | Buy → Neutral |
| Oct-21-25 | Resumed | Stifel | Buy |
| Oct-01-25 | Upgrade | Goldman | Neutral → Buy |
| Jun-16-25 | Initiated | Truist | Buy |
| Jun-12-25 | Initiated | Lake Street | Buy |
| May-30-25 | Initiated | Goldman | Neutral |
| May-30-25 | Initiated | Wolfe Research | Outperform |
| Feb-24-25 | Initiated | BofA Securities | Buy |
| Feb-24-25 | Initiated | Lake Street | Buy |
| Feb-24-25 | Initiated | Leerink Partners | Outperform |
| Feb-24-25 | Initiated | Piper Sandler | Overweight |
| Feb-24-25 | Initiated | Stifel | Buy |
| Feb-20-25 | Initiated | Ladenburg Thalmann | Neutral |
| Feb-20-25 | Initiated | Robert W. Baird | Neutral |
View All
Beta Bionics Inc Stock (BBNX) Latest News
Beta Bionics, Inc. Notice of November 3, 2026 Application Deadline for Class Action LawsuitContact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline - accessnewswire.com
November 3, 2026 Deadline: Join Class Action Lawsuit Against Beta Bionics, Inc. (BBNX)Contact Levi & Korsinsky - accessnewswire.com
BBNX Stockholders Have Rights – If You Lost Money Investing - GlobeNewswire
BBNX Stockholders Have Rights – If You Lost Money Investing in Beta Bionics, Inc. Contact Robbins LLP for Information About Recovering Your Losses - GlobeNewswire Inc.
BBNX Investors: Beta Bionics, Inc. Shares Declined By - GlobeNewswire
ALARUM DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Alarum Technologies Ltd. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - GlobeNewswire Inc.
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Beta Bionics, - GlobeNewswire
BBNX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Beta Bionics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - accessnewswire.com
Beta Bionics Shareholder Alert: ClaimsFiler Reminds - GlobeNewswire
Kaplan Fox Class Action Reminder: Beta Bionics, Inc. (NASDAQ: BBNX) Lead Plaintiff Deadline is November 3, 2026 - natlawreview.com
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A - GlobeNewswire
Truist Raises Price Target on Beta Bionics to $28 From $23, Keeps Buy Rating - finance.yahoo.com
Levi & Korsinsky Notifies Beta Bionics, Inc. (BBNX) InvestorsLead Plaintiff Deadline on November 3, 2026 - ACCESS Newswire
Beta Bionics, Inc. (BBNX) Stock Price, News, Quote & History - Yahoo! Finance Canada
Class Action Lawsuit Filed: Beta Bionics, Inc. (BBNX) – Join by November 3, 2026 – Contact Levi & Korsinsky - ACCESS Newswire
Kaplan Fox Shareholder Alert: Deadline to Lead in the Securities - natlawreview.com
BBNX Investors Have Opportunity to Lead Beta Bionics, Inc. Securities Fraud Lawsuit - PR Newswire
Contact Levi & Korsinsky by November 3, 2026 to Join Class Action Against Beta Bionics, Inc. (BBNX) - accessnewswire.com
Form 4 Beta Bionics Inc For: 23 September By Investing.com - Investing.com India
Beta Bionics director Christy Jones sells $147,890 in shares - Investing.com India
BBNX ALERT: Securities Fraud Class Action Launched Against Beta Bionics, Inc.November 3, 2026 Deadline - accessnewswire.com
Beta Bionics director Christy Jones sells $147,890 in shares By Investing.com - Investing.com Australia
Kaplan Fox Shareholder Alert: Deadline to Lead in the Securities Fraud Lawsuit Against Beta Bionics, Inc. (NASDAQ: BBNX) is November 3, 2026 - The Globe and Mail
After selling shares under a trading plan, director Christy Jones holds 19,564 Beta Bionics (BBNX) shares. - Stock Titan
Beta Bionics Price Target Announced at $28.00/Share by Wells Fargo - Moomoo
BBNX Investor Alert: Johnson Fistel Encourages Beta Bionics, Inc. Investors to Contact the Firm Ahead of November 3, 2026 Lead Plaintiff Deadline - PR Newswire
BBNX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Beta Bionics, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - accessnewswire.com
BBNX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announc - natlawreview.com
BBNX Investor Alert: Beta Bionics, Inc. Securities Class Action NoticeContact Levi & Korsinsky - PR Newswire
Wells Fargo initiates Beta Bionics stock with overweight rating By Investing.com - Investing.com Australia
Lead Plaintiff Deadlines in Shareholder Class Action - GlobeNewswire
Lost Money on Beta Bionics, Inc. (BBNX)? Join Class Action Before November 3, 2026Contact Levi & Korsinsky - ACCESS Newswire
Securities Lawsuit Alert: Beta Bionics, Inc. (BBNX)Contact Levi & Korsinsky Before November 3, 2026 - accessnewswire.com
Kaplan Fox Deadline Alert: Beta Bionics, Inc. (NASDAQ: BBNX) Investors Have Until November 3, 2026 to Seek a Lead Plaintiff Role - The Globe and Mail
Beta Bionics, Inc. Notice of November 3, 2026 Application - GlobeNewswire
Lost Money on Beta Bionics, Inc. (BBNX)? Contact Levi & Korsinsky to Join Class Action Before November 3, 2026 - accessnewswire.com
Beta Bionics (NASDAQ: BBNX) director lines up $197K stock sale - stocktitan.net
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Beta Bionics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionBBNX - TMX Newsfile
Beta Bionics, Senseonics to Integrate Diabetes Devices; Shares Rise - marketscreener.com
BBNX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Beta Bionics, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - accessnewswire.com
Deadline Alert: Beta Bionics, Inc. (BBNX) Shareholders Who - GlobeNewswire
BBNX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Anno - The National Law Review
Beta Bionics Up 7% on Senseonics Partnership - ocbj.com
BETA BIONICS, INC. (BBNX) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Beta Bionics, Inc. Investors of Upcoming Deadline - Carroll County Mirror-Democrat
Kaplan Fox Urges Beta Bionics, Inc. (NASDAQ: BBNX) Investors to Contact the Firm Before the Deadline on November 3, 2026 - NewMediaWire
BBNX Investor Alert: Schall, Brown & Schwartz LLP Files - GlobeNewswire
Beta Bionics partners with Senseonics on glucose monitoring By Investing.com - Investing.com Canada
Important Notice to Long-Term Shareholders of Aardvark - GlobeNewswire
Beta Bionics partners with Senseonics on glucose monitoring - Investing.com
Beta Bionics Announces Agreement Integrate the iLet® Bionic Pancreas and mint™ with Senseonics’ Eversense® 365 - The Manila Times
Beta Bionics Announces Partnership to Integrate iLet and mint AID Systems with Senseonics’ Eversense 365 CGM - Quiver Quantitative
Beta Bionics Inc Stock (BBNX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.31%
0.41%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):